KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Gross Margin (2016 - 2025)

Historic Gross Margin for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 61.76%.

  • Resmed's Gross Margin rose 31600.0% to 61.76% in Q4 2025 from the same period last year, while for Dec 2025 it was 60.87%, marking a year-over-year increase of 24800.0%. This contributed to the annual value of 59.36% for FY2025, which is 26900.0% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Gross Margin is 61.76%, which was up 31600.0% from 61.46% recorded in Q3 2025.
  • Resmed's Gross Margin's 5-year high stood at 61.76% during Q4 2025, with a 5-year trough of 54.44% in Q3 2023.
  • Its 5-year average for Gross Margin is 57.54%, with a median of 57.02% in 2022.
  • In the last 5 years, Resmed's Gross Margin tumbled by -24700bps in 2023 and then skyrocketed by 41400bps in 2024.
  • Resmed's Gross Margin (Quarter) stood at 56.36% in 2021, then decreased by 0bps to 56.08% in 2022, then dropped by -1bps to 55.64% in 2023, then rose by 5bps to 58.6% in 2024, then increased by 5bps to 61.76% in 2025.
  • Its Gross Margin was 61.76% in Q4 2025, compared to 61.46% in Q3 2025 and 60.84% in Q2 2025.